4//SEC Filing
Joyce James A 4
Accession 0001683168-18-000294
CIK 0000882291other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:32 PM ET
Size
8.0 KB
Accession
0001683168-18-000294
Insider Transaction Report
Form 4
Joyce James A
DirectorChair., Pres., CEO, CFO, Sec.10% Owner
Transactions
- Conversion
Restricted Stock Units
2018-01-31−39,625→ 397,939 total→ Common Stock (39,625 underlying) - Exercise/Conversion
Common Stock
2018-01-31$1.50/sh+16,979$25,469→ 156,233 total
Footnotes (3)
- [F1]In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised.
- [F3]158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of January 31, 2018.
Documents
Issuer
AETHLON MEDICAL INC
CIK 0000882291
Entity typeother
Related Parties
1- filerCIK 0001318931
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:32 PM ET
- Size
- 8.0 KB